Print Page | Report Abuse | Sign In | Register
ILCA Webinar - Radiation Oncology in the Management of HCC. Who and how should be treated
Tell a Friend About This EventTell a Friend
ILCA Webinar - Radiation Oncology in the Management of HCC. Who and how should be treated

ILCA offers a full range of online educational programmes delivered by scientific and medical experts from around the world exchanging the latest scientific advances and best practices in liver cancer research and care.

17/06/2021
When: Thursday, June 17, 2021
2:30 PM
Where: Webinar
Contact: Events ILCA
events@ilca-online.com
+32 (0)2 320 2531


Online registration is closed.
« Go to Upcoming Event List  

WEBINAR CHAIRS:

Tim Meyer, Professor of Experimental Cancer Medicine at UCL and Honorary Consultant in Medical Oncology at the Royal Free and ULCH Hospitals, London,UK

Laura Kulik, Hepatology & Liver Transplantation Professor, Medicine, Northwestern University Medical School, Chicago, USA

AGENDA:

  • Introductions and Webinar Objectives
  • SBRT for HCC – what is the evidence and who should we treat? With Laura Dawson, ASTRO President and Professor, Dept. of Radiation Oncology, University of Toronto, Canada
  • Proton Beam therapy – what does it add? With Joong-Won Park, Professor, Principal Scientist Center for Liver and Pancreatobiliary,  Cancer Graduate School of Cancer Science and Policy National Cancer Center, Korea 
  • Combining radiotherapy with systemic therapy – is there a rationale? With Jérôme Durand-Labrunie, Doctor, Radiation Oncology Department, Hepato-gastroenterology Gustave Roussy, Villejuif, France
  • Discussion and wrap up

EVENT PHOTOS

Copyright © International Liver Cancer Association. All Rights Reserved

This website uses cookies to store information on your computer. Some of these cookies are used for visitor analysis, others are essential to making our site function properly and improve the user experience. By using this site, you consent to the placement of these cookies. Click Accept to consent and dismiss this message or Deny to leave this website. Read our Privacy Statement for more.